Pristine Surgical
Private Company
Total funding raised: $2.5M
Overview
Pristine Surgical is a private, commercial-stage medical device company pioneering a 'Scopes as a Subscription' model for 4K single-use endoscopes. Its initial product, Summit™, is a single-use surgical arthroscope, supported by the Pristine Connect® cloud software for inventory management and data sharing. The company aims to disrupt the traditional reusable endoscope market by addressing high costs, maintenance burdens, and infection risks, with a pipeline targeting broader endoscopic applications like laparoscopy and flexible endoscopy. Backed by an experienced executive team and medical advisory board, Pristine is positioned to capitalize on the growing shift toward disposable medical devices.
Technology Platform
Integrated platform of 4K single-use endoscopes (hardware) and Pristine Connect® cloud-based software for inventory management, data sharing, and workflow automation.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Pristine competes directly with major orthopedic arthroscopy players like Stryker, Smith & Nephew, and Arthrex, who primarily sell reusable scopes. In the broader single-use endoscope space, competitors include Ambu (flexible endoscopes) and Boston Scientific (single-use duodenoscopes/cholangioscopes). Its key differentiation is the combination of 4K single-use hardware with a dedicated cloud software platform for workflow management.